Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 178

1.

Intravenous esomeprazole for prevention of peptic ulcer re-bleeding: rationale/design of Peptic Ulcer Bleed study.

Sung JJ, Mössner J, Barkun A, Kuipers EJ, Lau J, Jensen D, Stuart R, Junghard O, Olsson G; Pub Study Group.

Aliment Pharmacol Ther. 2008 Apr;27(8):666-77. doi: 10.1111/j.1365-2036.2008.03631.x. Epub 2008 Jan 28.

2.

Effect of oral esomeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers.

Wei KL, Tung SY, Sheen CH, Chang TS, Lee IL, Wu CS.

J Gastroenterol Hepatol. 2007 Jan;22(1):43-6.

PMID:
17201879
3.

Effects of intravenous and oral esomeprazole in the prevention of recurrent bleeding from peptic ulcers after endoscopic therapy.

Sung JJ, Suen BY, Wu JC, Lau JY, Ching JY, Lee VW, Chiu PW, Tsoi KK, Chan FK.

Am J Gastroenterol. 2014 Jul;109(7):1005-10. doi: 10.1038/ajg.2014.105. Epub 2014 Apr 29.

PMID:
24777150
4.

Safety and tolerability of high-dose intravenous esomeprazole for prevention of peptic ulcer rebleeding.

Kuipers EJ, Sung JJ, Barkun A, Mössner J, Jensen D, Stuart R, Lau JY, Ahlbom H, Lind T, Kilhamn J.

Adv Ther. 2011 Feb;28(2):150-9. doi: 10.1007/s12325-010-0095-5. Epub 2010 Dec 15.

PMID:
21181319
5.

Effect of intravenous proton pump inhibitor regimens and timing of endoscopy on clinical outcomes of peptic ulcer bleeding.

Liu N, Liu L, Zhang H, Gyawali PC, Zhang D, Yao L, Yang Y, Wu K, Ding J, Fan D.

J Gastroenterol Hepatol. 2012 Sep;27(9):1473-9. doi: 10.1111/j.1440-1746.2012.07191.x.

PMID:
22646140
6.

Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.

Leontiadis GI, Sreedharan A, Dorward S, Barton P, Delaney B, Howden CW, Orhewere M, Gisbert J, Sharma VK, Rostom A, Moayyedi P, Forman D.

Health Technol Assess. 2007 Dec;11(51):iii-iv, 1-164. Review.

7.

Oral or intravenous proton pump inhibitor in patients with peptic ulcer bleeding after successful endoscopic epinephrine injection.

Tsai JJ, Hsu YC, Perng CL, Lin HJ.

Br J Clin Pharmacol. 2009 Mar;67(3):326-32. doi: 10.1111/j.1365-2125.2008.03359.x. Epub 2008 Dec 10.

8.

Comparison of infusion or low-dose proton pump inhibitor treatments in upper gastrointestinal system bleeding.

Songür Y, Balkarli A, Acartürk G, Senol A.

Eur J Intern Med. 2011 Apr;22(2):200-4. doi: 10.1016/j.ejim.2010.11.007. Epub 2010 Dec 18.

PMID:
21402254
9.

Efficacy of an intravenous proton pump inhibitor after endoscopic therapy with epinephrine injection for peptic ulcer bleeding in patients with uraemia: a case-control study.

Tseng GY, Fang CT, Lin HJ, Yang HB, Tseng GC, Wang PC, Liao PC, Cheng YT, Huang CH.

Aliment Pharmacol Ther. 2009 Aug 15;30(4):406-13. doi: 10.1111/j.1365-2036.2009.04049.x. Epub 2009 May 26.

10.

Pantoprazole infusion as adjuvant therapy to endoscopic treatment in patients with peptic ulcer bleeding: prospective randomized controlled trial.

Zargar SA, Javid G, Khan BA, Yattoo GN, Shah AH, Gulzar GM, Sodhi JS, Mujeeb SA, Khan MA, Shah NA, Shafi HM.

J Gastroenterol Hepatol. 2006 Apr;21(4):716-21.

PMID:
16677158
11.

Intravenous esomeprazole for prevention of recurrent peptic ulcer bleeding: a randomized trial.

Sung JJ, Barkun A, Kuipers EJ, Mössner J, Jensen DM, Stuart R, Lau JY, Ahlbom H, Kilhamn J, Lind T; Peptic Ulcer Bleed Study Group.

Ann Intern Med. 2009 Apr 7;150(7):455-64. Epub 2009 Feb 16.

PMID:
19221370
12.

Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers.

Lau JY, Sung JJ, Lee KK, Yung MY, Wong SK, Wu JC, Chan FK, Ng EK, You JH, Lee CW, Chan AC, Chung SC.

N Engl J Med. 2000 Aug 3;343(5):310-6.

13.

Oral versus intravenous proton pump inhibitors in preventing re-bleeding for patients with peptic ulcer bleeding after successful endoscopic therapy.

Yen HH, Yang CW, Su WW, Soon MS, Wu SS, Lin HJ.

BMC Gastroenterol. 2012 Jun 8;12:66. doi: 10.1186/1471-230X-12-66.

14.

Continuous infusion of high-dose omeprazole is more effective than standard-dose omeprazole in patients with high-risk peptic ulcer bleeding: a retrospective study.

Simon-Rudler M, Massard J, Bernard-Chabert B, DI Martino V, Ratziu V, Poynard T, Thabut D.

Aliment Pharmacol Ther. 2007 Apr 15;25(8):949-54.

16.

Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding.

Chan FK, Ching JY, Hung LC, Wong VW, Leung VK, Kung NN, Hui AJ, Wu JC, Leung WK, Lee VW, Lee KK, Lee YT, Lau JY, To KF, Chan HL, Chung SC, Sung JJ.

N Engl J Med. 2005 Jan 20;352(3):238-44.

17.

Esomeprazole with aspirin versus clopidogrel for prevention of recurrent gastrointestinal ulcer complications.

Lai KC, Chu KM, Hui WM, Wong BC, Hung WK, Loo CK, Hu WH, Chan AO, Kwok KF, Fung TT, Wong J, Lam SK.

Clin Gastroenterol Hepatol. 2006 Jul;4(7):860-5. Epub 2006 Jun 22.

PMID:
16797240
18.

Effect of oral omeprazole in reducing re-bleeding in bleeding peptic ulcers: a prospective, double-blind, randomized, clinical trial.

Kaviani MJ, Hashemi MR, Kazemifar AR, Roozitalab S, Mostaghni AA, Merat S, Alizadeh-Naini M, Yarmohammadi H.

Aliment Pharmacol Ther. 2003 Jan;17(2):211-6.

19.

Randomized controlled trial of standard versus high-dose intravenous omeprazole after endoscopic therapy in high-risk patients with acute peptic ulcer bleeding.

Chan WH, Khin LW, Chung YF, Goh YC, Ong HS, Wong WK.

Br J Surg. 2011 May;98(5):640-4. doi: 10.1002/bjs.7420. Epub 2011 Feb 8.

PMID:
21305536
20.

Effect of proton pump inhibitors on the outcomes of peptic ulcer bleeding: comparison of event rates in routine clinical practice and a clinical trial.

Lanas A, Polo-Tomas M, García-Rodríguez LA, García S, Arroyo-Villarino MT, Ponce J, Bujanda L, Calleja JL, Calvet X, Feu F, Perez-Aisa A, Sung JJ.

Scand J Gastroenterol. 2013 Mar;48(3):285-94. doi: 10.3109/00365521.2012.758764. Epub 2013 Jan 8.

PMID:
23298283

Supplemental Content

Support Center